1. 4564 Nilotinib alters microRNAs that regulate specific autophagy and ubiquitination genes in the cerebrospinal fluid of Parkinson's patients. Issue Volume 4:Issue(2020)Supplement 1 (June 2020) Authors: Fowler, Alan; Torres-Yhagi, Yasar; Pagan, Fernando; Hebron, Michaeline; Willmarth, Barbara; Arellano, Joy; Howard, Helen; Matar, Sara; Chiu, Timothy; Ahn, Jaeil; Moussa, Charbel Journal: Journal of clinical and translational science Issue: Volume 4:Issue(2020)Supplement 1 Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P4–095]: NILOTINIB REDUCES PHOSPHORYLATED NEUROFILAMENTS AND CORRELATES WITH COGNITIVE IMPROVEMENT IN PARKINSON's DISEASE WITH DEMENTIA AND LEWY BODY DEMENTIA. (1st July 2017) Authors: E‐H Moussa, Charbel; Pagan, Fernando; Hebron, Michaeline Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 27 Page Start: P1294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease. Issue 1 (25th May 2016) Authors: Isaacson, Stuart; Lew, Mark; Ondo, William; Hubble, Jean; Clinch, Thomas; Pagan, Fernando Journal: Movement disorders clinical practice Issue: Volume 4:Issue 1(2017) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Changing the treatment paradigm for Parkinson's disease psychosis with pimavanserin. Issue 7 (3rd July 2019) Authors: Lyons, Kelly E.; Pahwa, Rajesh; Hermanowicz, Neal; Davis, Thomas; Pagan, Fernando; Isaacson, Stuart Journal: Expert review of clinical pharmacology Issue: Volume 12:Issue 7(2019) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combination Targeting of Subthalamic Nucleus and Ventral Intermediate Thalamic Nucleus in Deep Brain Stimulation for Tremor-Dominant Parkinson's Disease: Experience and Outcomes. (1st September 2019) Authors: Fayed, Islam; Cobourn, Kelsey Diva; Pivazyan, Gnel; Pagan, Fernando; Lo, Steven; Torres-Yaghi, Yasar; Mandir, Allen S; Kalhorn, Christopher G Journal: Neurosurgery Issue: Volume 66(2010)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Combination Targeting of Subthalamic Nucleus and Ventral Intermediate Thalamic Nucleus in Deep Brain Stimulation for Tremor‐Dominant Parkinson's Disease: Experience and Outcomes. (September 2019) Authors: Fayed, Islam; Cobourn, Kelsey Diva; Pivazyan, Gnel; Pagan, Fernando; Lo, Steven; Torres‐Yaghi, Yasar; Mandir, Allen S; Kalhorn, Christopher G Journal: Neurosurgery Issue: Volume 66(2019)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects. (3rd October 2021) Authors: Mitsikostas, Dimos D.; Dekundy, Andrzej; Hanschmann, Angelika; Althaus, Michael; Scheschonka, Astrid; Pagan, Fernando; Jankovic, Joseph Journal: Current medical research and opinion Issue: Volume 37:Number 10(2021) Page Start: 1761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Duration of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects: Results from a Phase III study. (January 2021) Authors: Mitsikostas, Dimos D.; Dekundy, Andrzej; Althaus, Michael; Scheschonka, Astrid; Pagan, Fernando; Jankovic, Joseph Journal: Toxicon Issue: Volume 190(2021)supplement 1 Page Start: S50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Duration of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin–naive subjects: Results from a phase 3 study. (December 2018) Authors: Mitsikostas, Dimos D.; Dekundy, Andrzej; Sternberg, Kati; Althaus, Michael; Scheschonka, Astrid; Pagan, Fernando; Jankovic, Joseph Journal: Toxicon Issue: Volume 156(2018)Supplement 1 Page Start: S81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of incobotulinumtoxinA for the treatment of sialorrhea: Results of the main phase of a phase 3 study. (December 2018) Authors: Jost, Wolfgang H.; Michel, Olaf; Oehlwein, Christian; Slawek, Jaroslaw; Bogucki, Andrzej; Ochudlo, Stanislaw; Banach, Marta; Pagan, Fernando; Flatau-Baqué, Birgit; Csikós, János; Blitzer, Andrew Journal: Toxicon Issue: Volume 156(2018)Supplement 1 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗